Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease - Six case-control studies from the Copenhagen City Heart Study

被引:53
作者
Sethi, AA
Tybjaerg-Hansen, A
Gronholdt, MLM
Steffensen, R
Schnohr, P
Nordestgaard, BG
机构
[1] Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Copenhagen, Denmark
[3] Herlev Univ Hosp, Copenhagen, Denmark
[4] Bispebjerg Hosp, Copenhagen, Denmark
关键词
D O I
10.7326/0003-4819-134-10-200105150-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The M235T and T174M angiotensinogen mutations have been linked to increased risk for ischemic heart and cerebrovascular disease. Objective: To determine whether angiotensinogen mutations are associated with ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Design: Six case-control studies from the Copenhagen City Heart Study. Setting: Copenhagen, Denmark. Participants: Participants in the Copenhagen City Heart Study and patients from the same hospital with ischemic heart disease (n = 866 and n = 943, respectively), myocardial infarction (n = 519 and n = 493, respectively), or ischemic cerebrovascular disease (n = 489 and n = 434, respectively) and 7975 controls without these conditions. Measurements: Genotypes for the M235T and T174M angiotensinogen mutations were compared between controls and Copenhagen City Heart Study participants with ischemic heart disease, myocardial infarction, and cerebrovascular disease (studies 1a, 1b, and 1c) and patients from Copenhagen University Hospital with the same conditions (studies 2a, 2b, and 2c). Results: Relative allele frequencies of 235T and 174M in the general population were 0.41 and 0.12, respectively. Genotype was not associated with increased risk for ischemic heart or ischemic cerebrovascular disease in studies of either mutation alone or combined in women or men. Among compound heterozygotes (235MT/174TM), women in case-control study 2a had decreased risk for ischemic heart disease in age-adjusted analysis; however, this decreased risk was not seen in multifactorial-adjusted or matched analyses, in men, or in case-control study 1a. Among double homozygotes (235TT/174MM), women in case-control study 2b had increased risk for myocardial infarction in matched analysis; however, this increased risk was not seen in age- or multifactorial-adjusted analyses, in men, or in case-control study 1b. Among single homozygotes (235TT/174TT), men in case-control study 2b had increased risk for myocardial infarction in multifactorial-adjusted and matched analyses. This risk was not present in age-adjusted analysis, in women, or in case-control study 1b. In addition, male single homozygotes had decreased risk for ischemic cerebrovascular disease in case-control study 2c in age- and multifactorial-adjusted analyses, but this finding was not seen in matched analysis, in women, or in case-control study 1c. Conclusions: In six large case-control studies, the M235T and T174M angiotensinogen mutations were not consistently associated with increased (or decreased) risk for ischemic heart disease, myocardial infarction, or ischemic cerebrovascular disease. Statistically significant associations may represent chance findings rather than real phenomena.
引用
收藏
页码:941 / 954
页数:14
相关论文
共 28 条
[11]   Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis [J].
Gardemann, A ;
Stricker, J ;
Humme, J ;
Nguyen, QD ;
Katz, N ;
Philipp, M ;
Tillmanns, H ;
Hehrlein, FW ;
Haberbosch, W .
ATHEROSCLEROSIS, 1999, 145 (02) :309-314
[12]   MOLECULAR-BASIS OF HUMAN HYPERTENSION - ROLE OF ANGIOTENSINOGEN [J].
JEUNEMAITRE, X ;
SOUBRIER, F ;
KOTELEVTSEV, YV ;
LIFTON, RP ;
WILLIAMS, CS ;
CHARRU, A ;
HUNT, SC ;
HOPKINS, PN ;
WILLIAMS, RR ;
LALOUEL, JM ;
CORVOL, P .
CELL, 1992, 71 (01) :169-180
[13]  
Julian DG, 1997, EUR HEART J, V18, P394
[14]   ASSOCIATION OF ANGIOTENSINOGEN GENE T235 VARIANT WITH INCREASED RISK OF CORONARY HEART-DISEASE [J].
KATSUYA, T ;
KOIKE, G ;
YEE, TW ;
SHARPE, N ;
JACKSON, R ;
NORTON, R ;
HORIUCHI, M ;
PRATT, RE ;
DZAU, VJ ;
MACMAHON, S .
LANCET, 1995, 345 (8965) :1600-1603
[15]   Association between the angiotensinogen 235T-variant and essential hypertension in whites - A systematic review and methodological appraisal [J].
Kunz, R ;
Kreutz, R ;
Beige, J ;
Distler, A ;
Sharma, AM .
HYPERTENSION, 1997, 30 (06) :1331-1337
[16]   Associations between candidate loci angiotensin-converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: The NHLBI Family Heart Study [J].
Ludwig, EH ;
Borecki, IB ;
Ellison, RC ;
Folsom, AR ;
Heiss, G ;
Higgins, M ;
Lalouel, JM ;
Province, MA ;
Rao, DC .
ANNALS OF EPIDEMIOLOGY, 1997, 7 (01) :3-12
[17]   Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease [J].
Nakata, Y ;
Katsuya, T ;
Rakugi, H ;
Takami, S ;
Sato, N ;
Kamide, K ;
Ohishi, M ;
Miki, T ;
Higaki, J ;
Ogihara, T .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (12) :1391-1395
[18]  
*NOR MJ SPSS INC, 1998, SPSS WIND BAS SYST U
[19]   Heterozygous lipoprotein lipase deficiency - Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease [J].
Nordestgaard, BG ;
Abildgaard, S ;
Wittrup, HH ;
Steffensen, R ;
Jensen, G ;
TybjaergHansen, A .
CIRCULATION, 1997, 96 (06) :1737-1744
[20]   The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort [J].
Schunkert, H ;
Hense, HW ;
GimenezRoqueplo, AP ;
Stieber, J ;
Keil, U ;
Riegger, GAJ ;
Jeunemaitre, X .
HYPERTENSION, 1997, 29 (02) :628-633